These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Micro-RNA29b enhances the sensitivity of glioblastoma multiforme cells to temozolomide by promoting autophagy. Xu JX; Yang Y; Zhang X; Luan XP Anat Rec (Hoboken); 2021 Feb; 304(2):342-352. PubMed ID: 32275350 [TBL] [Abstract][Full Text] [Related]
3. Enhanced cytotoxic effect of radiation and temozolomide in malignant glioma cells: targeting PI3K-AKT-mTOR signaling, HSP90 and histone deacetylases. Choi EJ; Cho BJ; Lee DJ; Hwang YH; Chun SH; Kim HH; Kim IA BMC Cancer; 2014 Jan; 14():17. PubMed ID: 24418474 [TBL] [Abstract][Full Text] [Related]
4. Simvastatin Induces Unfolded Protein Response and Enhances Temozolomide-Induced Cell Death in Glioblastoma Cells. Dastghaib S; Shojaei S; Mostafavi-Pour Z; Sharma P; Patterson JB; Samali A; Mokarram P; Ghavami S Cells; 2020 Oct; 9(11):. PubMed ID: 33105603 [TBL] [Abstract][Full Text] [Related]
5. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway. Li H; Chen L; Li JJ; Zhou Q; Huang A; Liu WW; Wang K; Gao L; Qi ST; Lu YT J Hematol Oncol; 2018 May; 11(1):70. PubMed ID: 29843746 [TBL] [Abstract][Full Text] [Related]
6. Lovastatin Enhances Cytotoxicity of Temozolomide via Impairing Autophagic Flux in Glioblastoma Cells. Zhu Z; Zhang P; Li N; Kiang KMY; Cheng SY; Wong VK; Leung GK Biomed Res Int; 2019; 2019():2710693. PubMed ID: 31662972 [TBL] [Abstract][Full Text] [Related]
7. The PI3K inhibitor GDC-0941 enhances radiosensitization and reduces chemoresistance to temozolomide in GBM cell lines. Shi F; Guo H; Zhang R; Liu H; Wu L; Wu Q; Liu J; Liu T; Zhang Q Neuroscience; 2017 Mar; 346():298-308. PubMed ID: 28147244 [TBL] [Abstract][Full Text] [Related]
8. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway. Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060 [TBL] [Abstract][Full Text] [Related]
9. Temozolomide treatment combined with AZD3463 shows synergistic effect in glioblastoma cells. Goker Bagca B; Ozates NP; Asik A; Caglar HO; Gunduz C; Biray Avci C Biochem Biophys Res Commun; 2020 Dec; 533(4):1497-1504. PubMed ID: 33109342 [TBL] [Abstract][Full Text] [Related]
11. A Key Role of DNA Damage-Inducible Transcript 4 (DDIT4) Connects Autophagy and GLUT3-Mediated Stemness To Desensitize Temozolomide Efficacy in Glioblastomas. Ho KH; Chen PH; Chou CM; Shih CM; Lee YT; Cheng CH; Chen KC Neurotherapeutics; 2020 Jul; 17(3):1212-1227. PubMed ID: 31916238 [TBL] [Abstract][Full Text] [Related]
12. Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting. Wang L; Tang S; Yu Y; Lv Y; Wang A; Yan X; Li N; Sha C; Sun K; Li Y Mol Pharm; 2021 Mar; 18(3):915-927. PubMed ID: 33417456 [TBL] [Abstract][Full Text] [Related]
13. Preconditioning with INC280 and LDK378 drugs sensitizes MGMT-unmethylated glioblastoma to temozolomide: Pre-clinical assessment. Das A; Alshareef M; Porto GBF; Infinger LK; Vandergrift WA; Lindhorst SM; Varma AK; Patel SJ; Cachia D J Neurol Sci; 2020 Nov; 418():117102. PubMed ID: 32866816 [TBL] [Abstract][Full Text] [Related]
14. Are There Thresholds in Glioblastoma Cell Death Responses Triggered by Temozolomide? He Y; Kaina B Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925722 [TBL] [Abstract][Full Text] [Related]
15. Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme. Li Z; Zhang J; Zheng H; Li C; Xiong J; Wang W; Bao H; Jin H; Liang P J Exp Clin Cancer Res; 2019 Aug; 38(1):380. PubMed ID: 31462285 [TBL] [Abstract][Full Text] [Related]
16. Ganoderic acid A holds promising cytotoxicity on human glioblastoma mediated by incurring apoptosis and autophagy and inactivating PI3K/AKT signaling pathway. Cheng Y; Xie P J Biochem Mol Toxicol; 2019 Nov; 33(11):e22392. PubMed ID: 31503386 [TBL] [Abstract][Full Text] [Related]
17. FK228 augmented temozolomide sensitivity in human glioma cells by blocking PI3K/AKT/mTOR signal pathways. Wu Y; Dong L; Bao S; Wang M; Yun Y; Zhu R Biomed Pharmacother; 2016 Dec; 84():462-469. PubMed ID: 27685789 [TBL] [Abstract][Full Text] [Related]
18. Momelotinib sensitizes glioblastoma cells to temozolomide by enhancement of autophagy via JAK2/STAT3 inhibition. Liu T; Li A; Xu Y; Xin Y Oncol Rep; 2019 Mar; 41(3):1883-1892. PubMed ID: 30664175 [TBL] [Abstract][Full Text] [Related]
19. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists. Liu Z; Jiang X; Gao L; Liu X; Li J; Huang X; Zeng T World Neurosurg; 2019 Aug; 128():e468-e477. PubMed ID: 31048057 [TBL] [Abstract][Full Text] [Related]
20. A steroidal saponin form Paris vietnamensis (Takht.) reverses temozolomide resistance in glioblastoma cells via inducing apoptosis through ROS/PI3K/Akt pathway. Zhang S; Lu Y; Li H; Ji Y; Fang F; Tang H; Qiu P Biosci Trends; 2020 May; 14(2):123-133. PubMed ID: 32173672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]